Legal & General Group PLC Rigel Pharmaceuticals Inc Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$0.72 - $1.56 $838 - $1,817	-1,165 Reduced 6.23%	17,528 $25,000
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $2,165 - $2,813	-2,024 Reduced 9.77%	18,693 $20,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $1,056 - $1,716	-943 Reduced 4.35%	20,717 $26,000
Q4 2022 Feb 14, 2023	SELL	$0.67 - $11.9 $28,444 - $505,202	-42,454 Reduced 66.22%	21,660 $32,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $1,619 - $17,958	1,472 Added 2.35%	64,114 $76,000
Q2 2022 Aug 22, 2022	SELL	$0.67 - $3.19 $3,069 - $14,616	-4,582 Reduced 6.82%	62,642 $71,000
Q1 2022 May 16, 2022	BUY	$2.22 - $3.45 $31 - $48	14 Added 0.02%	67,224 $201,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $9,808 - $14,836	4,156 Added 6.59%	67,210 $179,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $116,889 - $150,286	33,397 Added 112.61%	63,054 $229,000
Q2 2021 Aug 12, 2021	BUY	$3.09 - $4.54 $6,161 - $9,052	1,994 Added 7.21%	29,657 $129,000
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $12,954 - $19,064	3,867 Added 16.25%	27,663 $95,000
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $13,088 - $30,367	-7,353 Reduced 23.61%	23,796 $57,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $4,224 - $6,141	2,996 Added 10.64%	31,149 $57,000
Q1 2020 May 14, 2020	SELL	$1.27 - $3.0 $10,147 - $23,970	-7,990 Reduced 22.11%	28,153 $44,000
Q4 2019 Feb 13, 2020	BUY	$1.6 - $2.43 $9,521 - $14,460	5,951 Added 19.71%	36,143 $78,000
Q4 2018 Feb 15, 2019	BUY	$2.08 - $3.36 $5,200 - $8,400	2,500 Added 9.03%	30,192 $69,000
Q2 2018 Aug 10, 2018	BUY	$2.83 - $4.11 $4,015 - $5,832	1,419 Added 5.4%	27,692 $79,000
Q1 2018 May 17, 2018	SELL	$3.54 - $4.54 $33,191 - $42,567	-9,376 Reduced 26.3%	26,273 $93,000
Q4 2017 Feb 13, 2018	BUY	$3.23 - $4.3 $115,146 - $153,290	35,649	35,649 $137,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account